It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A stock index tracks a group of stocks to represent market performance, guiding benchmarks and passive investment strategies.
28,657 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Infineon is attracting attention as the market bet grows on AI-driven data-center power needs. The company’s edge in ...
FuelCell Energy led a broad pullback in the fuel-cell space, with Plug Power and Bloom Energy sliding as investors bo...
June volatility is shaking up high-flyers, turning attention to cash-flow winners. One stock stands out as a no-brain...
Interactive Brokers clients favored Nvidia after its record quarter, purchasing the stock as it pulled back from the ...
American Bitcoin reports an $82 million Q1 loss even as it mines a record 817 BTC. Lower BTC prices and rising reserv...
Grayscale argues that saylor’s strategy $1.5bb cashflow is being squeezed by a growing load of preferred-stock obliga...
Palantir surged about 9% after announcing a Sovereign-AI partnership with NVIDIA, aimed at secure, air-gapped governm...
The Supreme Court struck down broad emergency tariffs from the Trump era, erasing projected revenue and reigniting ur...
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...
Analysts lift Occidental targets to as high as $69, citing Permian efficiency and robust cash flow. Oil near $75 prov...
SK Hynix closed the largest foreign U.S. listing on record, raising $26.5 billion. Analysts question whether the 2026...